An observational study in Ascending Aorta Aneurysm and Dilation of the Ascending Aorta, sponsored by Tomsk National Research Medical Center of the Russian Academy of Sciences. Recruiting at 2 sites in Russian Federation. Open to participants aged 45 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-25.
Sponsored by Tomsk National Research Medical Center of the Russian Academy of Sciences · Observational
Clarification of indications for surgical correction in patients with borderline expansion of the ascending aorta
Expanding indications for surgical treatment of patients with borderline values of the ascending aorta
960 studies on the registry are indexed under Aneurysm; 175 are open to participants now.
This study's planned enrollment of 80 is below the median of 151 across 443 observational studies indexed under Aneurysm.
Browse Aneurysm studies →Tomsk National Research Medical Center of the Russian Academy of Sciences is the lead sponsor of 73 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with computed tomography-diagnosed ascending aortic dilation greater than 45 mm, less than 55 mm with tricuspid aortic valve compared to patients with bicuspid aortic valve and healthy volunteers
Exclusion Criteria:
Healthy patients with normal aortic dimensions
Other: aortic prosthetics
patients with ascending aortic dilation 45-55, tricuspid aortic valves operated on
Other: aortic prosthetics
patients with ascending aortic dilation 45-55, tricuspid aortic valves non operated
Other: aortic prosthetics
aortic prosthetics
death
death
Time frame: 30 day after operation
aorto-associated complications
rupture, dissection
Time frame: 30 day
increasing the diameter of the ascending aorta
increasing the diameter of the ascending aorta more than 55 mm
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tomsk National Research Medical Center of the Russian Academy of Sciences